Citigroup
IRWD icon

Citigroup’s Ironwood Pharmaceuticals IRWD Stock Holding History

Citigroup’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-450,000
Closed -$3.92M – 5683
2024
Q1 		$3.92M Hold
450,000
– – ﹤0.01% 1897
2023
Q4 		$5.15M Buy
+450,000
New +$4.45M ﹤0.01% 1572
2020
Q1 		– Sell
-27,700
Closed -$369K – 7687
2019
Q4 		$369K Sell
27,700
-20,200
-42% -$223K ﹤0.01% 4690
2019
Q3 		$411K Buy
47,900
+41,700
+673% +$405K ﹤0.01% 4527
2019
Q2 		$68K Buy
6,200
+2,857
+85% +$32K ﹤0.01% 6210
2019
Q1 		$38K Buy
3,343
+119
+4% +$1.33K ﹤0.01% 6556
2018
Q4 		$28K Sell
3,224
-716
-18% -$8.22K ﹤0.01% 6686
2018
Q3 		$61K Sell
3,940
-12,179
-76% -$193K ﹤0.01% 6351
2018
Q2 		$258K Buy
16,119
+16,000
+13,445% +$237K ﹤0.01% 4794
2018
Q1 		$2K Sell
119
-6,806
-98% -$84.8K ﹤0.01% 7361
2017
Q4 		$87K Buy
6,925
+5,373
+346% +$70.2K ﹤0.01% 5759
2017
Q3 		$21K Sell
1,552
-3,105
-67% -$42.7K ﹤0.01% 6424
2017
Q2 		$74K Sell
4,657
-1,432
-24% -$20.8K ﹤0.01% 5547
2017
Q1 		$87K Sell
6,089
-16,955
-74% -$232K ﹤0.01% 5306
2016
Q4 		$295K Buy
23,044
+358
+2% +$4.52K ﹤0.01% 4948
2016
Q3 		$302K Buy
+22,686
New +$265K ﹤0.01% 4340
2013
Q4 		– Sell
-28,059
Closed -$278K – 7063
2013
Q3 		$278K Buy
+28,059
New +$275K ﹤0.01% 3891

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Citigroup's IRWD Position: Q2 2026 in Review

Citigroup increased its Ironwood Pharmaceuticals (IRWD) stake by 476% in Q2 2026, buying an estimated $722K and bringing the position to 226,824 shares worth $955K. The position accounts for ﹤0.01% of the portfolio, ranked #3475.

Citigroup first reported a position in IRWD in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.25M in Q1 2024. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Citigroup held 226,824 shares of Ironwood Pharmaceuticals worth $955K as of Q2 2026.
  • Citigroup bought 187,419 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $722K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3475 holding.
  • Citigroup first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Ironwood Pharmaceuticals position peaked at $8.25M in Q1 2024.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.